Klotho Neurosciences, Inc. (KLTO)
NASDAQ: KLTO · Real-Time Price · USD
0.4917
+0.0407 (9.02%)
At close: Oct 3, 2025, 4:00 PM EDT
0.4900
-0.0017 (-0.35%)
After-hours: Oct 3, 2025, 7:57 PM EDT
Klotho Neurosciences Market Cap
Klotho Neurosciences has a market cap or net worth of $30.18 million as of October 3, 2025. Its market cap has increased by 96.80% in one year.
Market Cap
30.18M
Enterprise Value
21.75M
1-Year Change
96.80%
Ranking
Category
Stock Price
$0.49
Market Cap Chart
Since April 29, 2022, Klotho Neurosciences's market cap has decreased from $127.33M to $30.18M, a decrease of -76.30%. That is a compound annual growth rate of -34.26%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 3, 2025 | 30.18M | 192.62% |
| Dec 31, 2024 | 10.31M | -89.05% |
| Dec 22, 2023 | 94.18M | -37.22% |
| Dec 20, 2022 | 150.02M | 17.82% |
| Apr 29, 2022 | 127.33M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 736.01B |
| Johnson & Johnson | 447.90B |
| AbbVie | 417.90B |
| UnitedHealth Group | 320.35B |
| AstraZeneca | 259.06B |
| Novo Nordisk | 258.32B |
| Novartis AG | 251.99B |
| Abbott Laboratories | 231.46B |